Avecho Biotechnology Ltd (AVE) - Total Liabilities

Latest as of December 2025: AU$5.55 Million AUD ≈ $3.92 Million USD

Based on the latest financial reports, Avecho Biotechnology Ltd (AVE) has total liabilities worth AU$5.55 Million AUD (≈ $3.92 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Avecho Biotechnology Ltd to track the company's year-over-year net asset growth rate.

Avecho Biotechnology Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how Avecho Biotechnology Ltd's total liabilities have evolved over time, based on quarterly financial data. See Avecho Biotechnology Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Avecho Biotechnology Ltd Competitors by Total Liabilities

The table below lists competitors of Avecho Biotechnology Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Cineverse Corp. NASDAQ:CNVS	USA	$30.83 Million
The Ugar Sugar Works Limited NSE:UGARSUGAR	India	Rs10.87 Billion
Gunawan Dianjaya Steel Tbk JK:GDST	Indonesia	Rp1.63 Trillion
Skycorp Solar Group Limited Ordinary Shares NASDAQ:PN	USA	$23.02 Million
High Roller Technologies, Inc. NYSE MKT:ROLR	USA	$9.46 Million
Copenhagen Capital A/S CO:CPHCAP-ST	Denmark	Dkr649.40 Million
De Poan Pneumatic TWO:1570	Taiwan	NT$105.16 Million
JW Shinyak Corporation KQ:067290	Korea	₩26.02 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Avecho Biotechnology Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Avecho Biotechnology Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.56	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.78	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avecho Biotechnology Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avecho Biotechnology Ltd (1993–2025)

The table below shows the annual total liabilities of Avecho Biotechnology Ltd from 1993 to 2025.

Year	Total Liabilities	Change
2025-12-31	AU$5.55 Million ≈ $3.92 Million	+221.15%
2024-12-31	AU$1.73 Million ≈ $1.22 Million	+83.43%
2023-12-31	AU$941.54K ≈ $666.20K	+2.27%
2022-12-31	AU$920.66K ≈ $651.42K	+29.79%
2021-12-31	AU$709.36K ≈ $501.92K	+1.31%
2020-12-31	AU$700.17K ≈ $495.41K	+25.90%
2019-12-31	AU$556.12K ≈ $393.49K	-38.35%
2018-12-31	AU$902.04K ≈ $638.25K	-50.87%
2017-12-31	AU$1.84 Million ≈ $1.30 Million	+7.52%
2016-12-31	AU$1.71 Million ≈ $1.21 Million	-5.97%
2015-12-31	AU$1.82 Million ≈ $1.28 Million	-3.04%
2014-12-31	AU$1.87 Million ≈ $1.33 Million	-14.36%
2013-12-31	AU$2.19 Million ≈ $1.55 Million	+44.93%
2012-12-31	AU$1.51 Million ≈ $1.07 Million	-58.44%
2011-12-31	AU$3.63 Million ≈ $2.57 Million	-75.40%
2010-12-31	AU$14.76 Million ≈ $10.44 Million	-15.04%
2009-12-31	AU$17.38 Million ≈ $12.29 Million	-1.48%
2008-12-31	AU$17.64 Million ≈ $12.48 Million	-53.29%
2007-12-31	AU$37.76 Million ≈ $26.72 Million	-0.69%
2006-12-31	AU$38.02 Million ≈ $26.90 Million	-2.35%
2005-12-31	AU$38.94 Million ≈ $27.55 Million	+4702.46%
2004-12-31	AU$810.73K ≈ $573.64K	+3127.69%
2003-12-31	AU$25.12K ≈ $17.77K	-17.24%
2002-12-31	AU$30.35K ≈ $21.47K	-46.21%
2001-12-31	AU$56.42K ≈ $39.92K	-69.54%
2000-12-31	AU$185.25K ≈ $131.08K	+156.71%
1999-12-31	AU$72.16K ≈ $51.06K	+117.59%
1998-12-31	AU$33.16K ≈ $23.47K	-54.87%
1997-12-31	AU$73.48K ≈ $51.99K	-98.74%
1996-12-31	AU$5.84 Million ≈ $4.13 Million	+4.60%
1995-12-31	AU$5.58 Million ≈ $3.95 Million	+1368.16%
1994-12-31	AU$380.00K ≈ $268.87K	-73.95%
1993-12-31	AU$1.46 Million ≈ $1.03 Million	--

About Avecho Biotechnology Ltd

AU:AVE Australia Biotechnology

Market Cap

$54.68 Million

AU$77.27 Million AUD

Market Cap Rank

#21544 Global

#742 in Australia

Share Price

AU$0.02

Change (1 day)

+5.26%

52-Week Range

AU$0.00 - AU$0.02

All Time High

AU$0.04